The FDA sent a letter to transplant surgeons and cardiologists on Oct. 26 with additional results regarding issues with SynCardia Systems, Inc.’s temporary total artificial heart companion 2 driver system (TAH-t C2 Driver System). The system serves as a bridge to a heart transplant for some heart failure patients.

A cardiologist from Long Island, New York, pleaded guilty Oct. 25 to first-degree criminal possession of a weapon, criminal sale of a drug prescription, third-degree arson and conspiracy to commit an assault, Newsday reports.

A study of young, non-smoking adults found that those who were exposed to fine particulate matter, known as PM2.5, had blood vessel damage and inflammation that could increase cardiovascular disease risk and lead to premature cardiovascular mortality.

Healthy adults who have high levels of calcium intake are not at an increased risk of cardiovascular disease, according to a systematic review and meta-analysis.

Cardiogram, a health tech startup in San Francisco, has raised $2 million to develop an app that shows a user’s cardio health while providing tips on how to improve and maintain a healthy heart.

A new study to examine the efficacy of an implantable hypertension treatment has been approved by the U.S. Food and Drug Administration.

Editors from the New England Journal of Medicine are seeking researchers, data analysts and patients to participate in the journal’s SPRINT data analysis challenge.

A recent retrospective cohort study confirmed the significant survival benefit of cardiac rehabilitation during the year following an acute MI, although other health status outcomes were similar among patients who did and did not participate in the programs.